N. Brack

539 citations
11 papers · 332 indexed · h-index 7

N. Brack

11 papers receiving 315 citations

Peers

N. Brack
Comparison fields: 5 of 44
  • Biochemistry 123
  • Hematology 185
  • Internal Medicine 22
  • Genetics 62
  • Critical Care and Intensive Care Medicine 29
Replace Knut Wendelin with:
Knut Wendelin Germany
Claire Dyer United Kingdom
Barbara Nowicki United States
John Bæch Denmark
Eapen K. Jacob United States
J Aisner United States
C Sarkodee-Adoo United States
G. Lercari Italy
G. R. Hazlehurst United Kingdom
M. Cole‐Sinclair Australia
N. Brack relative to Knut Wendelin Germany Knut Wendelin's profile →
Citations per field
00.5×1.5×
Knut Wendelin · 1×
Citations per year

Countries citing papers authored by N. Brack

Since Specialization
Citations

This map shows the geographic impact of N. Brack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Brack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Brack more than expected).

Fields of papers citing papers by N. Brack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Brack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Brack. The network helps show where N. Brack may publish in the future.

Co-authorship network

The 25 scholars most cited alongside N. Brack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with N. Brack Line = papers co-authored together N. Brack links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 20022
2 20024
3 20006
4 200014
5 200019
6 1998200
7 19985
8 199624
9
[Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
19962
10 199530
11
Recombinant human interferon-alpha in the treatment of angioimmunoblastic lymphadenopathy: results in 12 patients.
199126

About N. Brack

N. Brack is a scholar working on Hematology, Genetics and Oncology, having authored 11 papers that have together received 332 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Neutropenia and Cancer Infections (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Tumors and Oncological Cases (1 paper) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). The work is most often cited by research in Biochemistry (123 citations), Hematology (185 citations) and Internal Medicine (22 citations). N. Brack has collaborated with scholars based in Germany and Italy. Frequent co-authors include R. Hartenstein, Burkhard Otremba, Monika Raab, P. Harms, Markus H. Frank, B. Löffler, Christiane Schneider, Thomas Geer, Gerhard Ehninger and I. Fackler-Schwalbe. Their work appears in journals such as Cancer, Blood, British Journal of Haematology, Annals of Hematology and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026